29096-76-2 Usage
Class
Phenylimidazoles
Explanation
Phenylimidazoles are a class of organic compounds that contain a benzene ring fused to an imidazole ring. 1H-Benzimidazole-2-methanamine,5,6-dichlorois a derivative of benzimidazole, which falls under this class.
Explanation
The compound is a pale yellow solid, which refers to its physical state and color.
Explanation
1H-Benzimidazole-2-methanamine,5,6-dichloro- is mainly used as a starting material or intermediate in the production of various pharmaceuticals and agricultural chemicals, indicating its importance in the chemical industry.
Explanation
The structure of 1H-Benzimidazole-2-methanamine,5,6-dichlorocontains two chlorine atoms, which may contribute to its reactivity and potential applications in various chemical reactions.
Explanation
More research and testing are needed to gain a comprehensive understanding of the compound's properties, reactivity, and possible applications in various fields, such as pharmaceuticals and agriculture.
Appearance
Pale yellow solid
Primary Use
Intermediate in the synthesis of pharmaceuticals and agricultural chemicals
Chlorine Content
Two chlorine atoms
Further Research
Required to fully understand properties and potential uses
Check Digit Verification of cas no
The CAS Registry Mumber 29096-76-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,0,9 and 6 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 29096-76:
(7*2)+(6*9)+(5*0)+(4*9)+(3*6)+(2*7)+(1*6)=142
142 % 10 = 2
So 29096-76-2 is a valid CAS Registry Number.
29096-76-2Relevant academic research and scientific papers
Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer
Monastyrskyi, Andrii,Nilchan, Napon,Quereda, Victor,Noguchi, Yoshihiko,Ruiz, Claudia,Grant, Wayne,Cameron, Michael,Duckett, Derek,Roush, William
, p. 590 - 602 (2018/01/01)
Casein kinase 1δ/ε have been identified as promising therapeutic target for oncology application, including breast and brain cancer. Here, we described our continued efforts in optimization of a lead series of purine scaffold inhibitors that led to identification of two new CK1δ/ε inhibitors 17 and 28 displaying low nanomolar values in antiproliferative assays against the human MDA-MB-231 triple negative breast cancer cell line and have physical, in vitro and in vivo pharmacokinetic properties suitable for use in proof of principle animal xenograft studies against human cancers.
BENZIMIDAZOLE INHIBITORS OF THE SODIUM CHANNEL
-
Page/Page column 51; 55, (2012/09/21)
The invention relates to compounds useful in treating conditions associated with voltage-gated ion channel function, particularly conditions associated with sodium channel activity. More specifically, the invention concerns compounds (e.g., compounds according to any of Formulas (I)-(XIII) or Compounds (1)-(236) of Table 1) that are useful in treatment of a variety of diseases and conditions. Formula (I)
